FT576 is an investigational, universal, off-the-shelf NK cell cancer immunotherapy.
SparkCures ID | 430 |
---|---|
Developed By | Fate Therapeutics |
Generic Name | FT576 |
Treatment Classifications |
|
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
November 19, 2021